Your browser doesn't support javascript.
loading
Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting.
Argenziano, Monica; Occhipinti, Sergio; Scomparin, Anna; Angelini, Costanza; Novelli, Francesco; Soster, Marco; Giovarelli, Mirella; Cavalli, Roberta.
Afiliação
  • Argenziano M; Department of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125, Turin, Italy.
  • Occhipinti S; Department of Molecular Biotechnology and Health Science, University of Turin, Via Nizza 52, 10126, Turin, Italy.
  • Scomparin A; Department of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125, Turin, Italy.
  • Angelini C; Department of Molecular Biotechnology and Health Science, University of Turin, Via Nizza 52, 10126, Turin, Italy.
  • Novelli F; Department of Molecular Biotechnology and Health Science, University of Turin, Via Nizza 52, 10126, Turin, Italy.
  • Soster M; Department of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125, Turin, Italy.
  • Giovarelli M; Department of Molecular Biotechnology and Health Science, University of Turin, Via Nizza 52, 10126, Turin, Italy.
  • Cavalli R; Department of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125, Turin, Italy. roberta.cavalli@unito.it.
Drug Deliv Transl Res ; 12(8): 2007-2018, 2022 08.
Article em En | MEDLINE | ID: mdl-35672651

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Quitosana / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Drug Deliv Transl Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Quitosana / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Drug Deliv Transl Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália